BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3203168)

  • 21. Inhibitory histamine receptors in the rat vas deferens.
    Liao CS; Day AR; Freer RJ
    Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):173-6. PubMed ID: 7255870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotoninergic involvement in the cimetidine-induced prolactin release.
    Becú D; Libertun C
    Endocrinology; 1983 Dec; 113(6):1980-4. PubMed ID: 6227473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central H1 and H2 receptor participation in the control of water and salt intake in rats.
    Magrani J; de Castro e Silva E; Ramos AC; Athanazio R; Barbetta M; Fregoneze JB
    Physiol Behav; 2005 Feb; 84(2):233-43. PubMed ID: 15708775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroid hormone secretion in normal man and in primary hyperparathyroidism: role of histamine H2 receptors.
    Williams GA; Longley RS; Bowser EN; Hargis GK; Kukreja SC; Vora NM; Johnson PA; Jackson BL; Kawahara WJ; Henderson WJ
    J Clin Endocrinol Metab; 1981 Jan; 52(1):122-7. PubMed ID: 7451639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of H1 and H2 histamine receptor antagonists on positive feed-back effect of estrogen on LH in prepubertal female rats.
    Moguilevsky JA; Szwarcfarb B; Faigón MR; Paolini J; Scacchi P
    Horm Metab Res; 1989 Dec; 21(12):658-60. PubMed ID: 2613180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of taurine on growth hormone and prolactin secretion in rats: possible interaction with opioid peptidergic system.
    Ikuyama S; Okajima T; Kato K; Ibayashi H
    Life Sci; 1988; 43(10):807-12. PubMed ID: 3412107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiorespiratory responses to D-Ala-2-Me-Phe-4-Met-(O)-ol-enkephalin after administration into the fourth cerebral ventricle of the rat: interaction with cholinergic mechanisms.
    Rabkin SW
    Pharmacology; 1991; 42(2):68-78. PubMed ID: 2062874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of stimulation of dopamine and histamine receptors on spontaneous lymphocyte adhesion in vitro].
    Kharkevich DD
    Biull Eksp Biol Med; 1987 Jun; 103(6):703-5. PubMed ID: 3593954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histaminergic H1 and H2 receptors do not mediate cortisol release in response to naloxone in normal men.
    Coiro V; Chiodera P; Volpi R; Salati G; Ferrari P; Caiazza A; Rossi G
    Biomed Pharmacother; 1984; 38(7):358-60. PubMed ID: 6098319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin response to TRH after intravenous cimetidine.
    Scarpignato C; Bertaccini G; Ceda GP; Valenti G
    Farmaco Sci; 1979 Aug; 34(8):726-8. PubMed ID: 111967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cardiovascular effects of thyrotropin-releasing hormone (TRH) are attenuated by cimetidine in rats.
    Nurminen ML; Paakkari I; Jrvinen A; Vonhof S
    Pharmacol Toxicol; 1991 Nov; 69(5):322-6. PubMed ID: 1803344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central effect of the enkephalin analogue FK-33824 on vasopressin secretion in conscious sheep.
    Wang XM; Tresham JJ; Congiu M; Scoggins BA; Coghlan JP
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):369-73. PubMed ID: 2929239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histaminergic agents can modulate adrenergic smooth muscle neurotransmission.
    Todorov S; Zamfirova R
    Methods Find Exp Clin Pharmacol; 1985 Jul; 7(7):357-60. PubMed ID: 2997560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACTH1-24 counteracts the prolactin-releasing effect of an opioid.
    Ferri S; Cocchi D; Locatelli V; Spampinato S; Muller E
    Eur J Pharmacol; 1982 Jan; 77(2-3):143-5. PubMed ID: 6277660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central opioid receptor activity in patients affected by puerperal, idiopathic and tumoral hyperprolactinemia.
    De Leo V; Petraglia F; Sardelli S; De Leo M; Genazzani AR; D'Antona N
    Gynecol Obstet Invest; 1985; 19(3):160-5. PubMed ID: 2991091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of histamine, H1- and H2-receptor antagonists on the activity of serotonergic neurons in the dorsal raphe nucleus.
    Lakoski JM; Aghajanian GK
    J Pharmacol Exp Ther; 1983 Nov; 227(2):517-23. PubMed ID: 6138428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Central and cardiac histamine receptors involvement in the anti-arrhythmic effect of cimetidine].
    Li YS; Fu SX
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):248-51. PubMed ID: 6242215
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of cimetidine and ranitidine on gastric transmural potential difference and on prolactin secretion in man.
    von Kleist D; Gräf KJ; Dougherty FC; Hampel KE
    Hepatogastroenterology; 1981 Aug; 28(4):210-2. PubMed ID: 6115806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediation of the stress-induced prolactin release by hypothalamic histaminergic neurons and the possible involvement of vasopressin in this response.
    Kjaer A; Knigge U; Olsen L; Vilhardt H; Warberg J
    Endocrinology; 1991 Jan; 128(1):103-10. PubMed ID: 1986913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.